Skip to main content
. 2018 Nov 28;9:726. doi: 10.3389/fendo.2018.00726

Table 2.

General characteristics of study participants.

Placebo group Chromium group Pa
(n = 20) (n = 20)
Age (years) 33.8 ± 1.9 33.3 ± 2.7 0.55
Height (cm) 163.6 ± 1.9 164.2 ± 2.0 0.34
Weight at study baseline (kg) 72.2 ± 10.5 74.5 ± 7.0 0.41
Weight at end-of-trial (kg) 72.3 ± 10.4 74.5 ± 7.2 0.44
Weight change (kg) 0.1 ± 0.4 −0.02 ± 0.4 0.26
BMI at study baseline (kg/m2) 27.0 ± 3.9 27.7 ± 2.5 0.53
BMI at end-of-trial (kg/m2) 27.0 ± 3.9 27.6 ± 2.6 0.56
BMI change (kg/m2) 0.04 ± 0.1 −0.008 ± 0.1 0.25
OUTCOMES OF IVF AT END-OF-TRIAL
Endometrial thickness (mm) 8.9 ± 1.2 9.4 ± 1.5 0.28
No. of oocytes retrieved (n) 16.5 ± 2.8 15.5 ± 1.9 0.20
No. of fertilized oocytes (n) 12.6 ± 2.5 13.6 ± 3.2 0.34
Fertilization rate, % (n) 58.8 (10/17) 64.7 (11/17) 0.72
Pregnancy rate, % (n) 23.5 (4/17) 29.4 (5/17) 0.69
No. of embryo (n) 9.8 ± 2.1 10.9 ± 2.4 0.15

Data are means ± SDs.

a

Obtained from independent t-test.

Obtained from Fisher's exact test.

BMI, body mass index; IVF, in vitro fertilization.